From: Alveolar epithelial type II cell: defender of the alveolus revisited
Function/Product | Related to | Reference |
Fluid and electrolyte balance | Â | Â |
   Water channels |  |  |
Aquaporin 1 | Â | [218] |
Aquaporin 5 | Â | [219] |
Hg-insensitive channel (MIWC) | Â | [220] |
Hg-sensitive channel (CHIP28) | Â | [221] |
   Ion channels |  |  |
H+-channel | Â | [222] |
Na+-channel | Â | [223] |
Cl--channel | Â | [224] |
   Ion pumps |  |  |
H+-pump | pH of hypophase fluid | [30] |
Cl-/HCO3-anion exchanger | In vitro | [225] |
Na+/H+-ion exchanger | Â | [226] |
Na+/K+-atpase | Membrane potential | |
   Others |  |  |
Protein clearance | Â | [229] |
Carbanhydrase II | Â | [230] |
Components of innate defence | Â | Â |
   Surfactant components |  |  |
SP-A | Â | |
SP-D | Â | |
Lysozyme | Â | |
   Antigen presentation |  |  |
MHC class II | Human (adult, foetal) | |
 | IFN-stimulation | [171] |
HLA class I | IFN-stimulation | [233] |
Fc-receptor | Cell line A549, not present in vivo | [234] |
CD80, CD86 | Â | [234] |
   Complement complex |  |  |
C2, C3, C4, C5 | Â | [235] |
   Antiproteases |  |  |
α1-antitrypsin |  | |
Elafin | Cell line A549 | [238] |
Matrix metalloproteinase (MMP) | Â | [239] |
MMP-inhibitors (TIMP) | Â | [239] |
   Oxidants |  |  |
NAD(P)H-oxidase | Â | [240] |
Superoxide anion, hydrogen peroxide | Â | [240] |
   Antioxidants |  |  |
Glutathione | Â | [241] |
γ-glutamyl transferase |  | [242] |
Plasmalogens | Protection of surfactant | [192] |
Mn superoxide dismutase (SOD) | In vitro | [243] |
Mn-, Cu-, Zi-SOD | In vitro | [244] |
   Metabolism of Xenobiotics |  |  |
Cytochrome P-450 mono-oxygenase | Â | [245] |
Coagulation/fibrinolysis | Â | Â |
   Fibrinogen |  | [246] |
   Urokinase-type plasminogen activator (uPA) |  | [247] |
   UPA receptor | IL-1β stimulation | [248] |
   Plasminogen activator inhibitor (PA-I) |  | |
   Tissue factor | In bleomycin-induced injury | |
Cytokines/receptors | Â | [251] |
   Cytokines |  |  |
GM-CSF | In vitro | [165] |
IL-1β | Upon interaction with particles | [252] |
IL-4 | Human, interstitial lung disease | [253] |
IL-6 | Upon interaction with particles | [252] |
IL-8 | IL-1, TNF-α stimulation | |
IL-11 | In vitro | [257] |
Interferon-γ | Human, interstitial lung disease | [253] |
MCP-1 | In vitro | [258] |
RANTES | After TNF-α stimulation | [173] |
Tumour necrosis factor (TNF)-α | Hyperplastic type II cells | |
   Cytokine receptors |  |  |
IL-2-receptor | In vitro | [261] |
TNF-receptor | In vitro | [262] |
Lymphotoxin-β-receptor | Hyperplastic type II cells | [263] |
Growth factors/receptors | Â | Â |
   Growth factors |  |  |
Epidermal growth factor (EGF) | In vitro | [264] |
IGF-II | Â | [214] |
Platelet derived growth factor (PDGF) | Idiopathic lung fibrosis | [182] |
TGF-α |  | [265] |
TGF-β | Hyperplastic type II cells | [266] |
TGF-β1 | Hyperplastic type II cells | [267] |
TGF-β3 | Normal type II cells | [268] |
Vascular endothelial growth factor (VEGF) | Â | [269] |
   Growth factor receptors |  |  |
Basic fibroblast growth factor-receptor | Â | [270] |
EGF-receptor | Â | [271] |
Hepatocyte growth factor-receptor | Â | [162] |
KGF-receptor | During ontogenesis | |
IGF-receptor-1 | Early postnatal phase | [274] |
IGF-receptor-2 | Â | [214] |
Components of cell–cell interaction |  |  |
   Gap junction proteins |  |  |
Connexin 43 | Electric, ionic coupling | [142] |
   Adhesion molecules |  |  |
CD44s, CD44v | Â | [275] |
Ep-Cam | Â | [146] |
E-cadherin | Â | [276] |
ICAM-1 | After TNF-α stimulation | |
VCAM-1 | After TNF-α stimulation | [173] |
   Integrins |  |  |
α6 β1 | In vitro | [278] |
α3 β1 | In vitro | [278] |
   Paracrine-acting molecules |  |  |
Endothelin-1 | Human | [279] |
Endothelin receptor A | Rat cell line L2 | [159] |
Prostaglandin E-2 | Â | [280] |
Prostacyclin | Â | [280] |
Nitrogen oxide (NO) | In vitro | |
Constitutive NO synthase | Human cell line A859 | [283] |
Inducible NO synthase | In vitro, rat cell line L2 | |
Components of extracellular matrix | Â | Â |
Entactin | Basal membrane, in vitro | [285] |
Laminin | Basal membrane, in vitro | [278] |
Fibronectin | In vitro | |
Tenascin | Early organogenesis | [288] |
 | Hyperplastic type II cells | [289] |
Proteoglycans | In vitro | [290] |
Collagen type IV | Â |